Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Horizon Pharma plc to Participate in Investor Conferences in November

Horizon Pharma plc
Posted on: 25 Oct 18

Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conferences in November:

Stifel 2018 Healthcare Conference

  • Date: Wednesday, Nov. 14, 2018
  • Presentation Time: 10:15 a.m. EST
  • Location: New York, NY

Jefferies 2018 London Healthcare Conference

  • Date: Thursday, Nov. 15, 2018
  • Presentation Time: 10 a.m. GMT
  • Location: London, United Kingdom

The presentations will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcast will be available for each event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit, follow us @HZNPplc on Twitter or like us on Facebook.

View source version on

Business Wire

Last updated on: 25/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.